Aster DM Healthcare Ltd

About Company

Incorporated in 1987, Aster DM Healthcare Ltd is Kochi, Kerala based healthcare service provider with operations in GCC states (United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait and Bahrain), India and the Philippines. Company’s Indian operations are headquartered in Kochi, Kerala.

Aster DM Healthcare operates in multiple segments of the healthcare industry including hospitals, clinics and retail pharmacies. Company operates hospitals and clinics, pharmacies, diagnostic centers, educational institutions, and healthcare management and healthcare support systems. Company provides healthcare services to patients across economic segments under brand names including "Aster", "Medcare" and "Access".

Aster's healthcare facilities consist of 9 hospitals, 90 clinics and 206 retail pharmacies in the GCC states, 10 multi-specialty hospitals and 7 clinics in India, and 1 clinic in the Philippines as of September 30, 2017. Aster's had 17,408 employees as of September 30, 2017, including 1,417 full time doctors, 5,797 nurses, 1,752 paramedics and 8,442 other employees (including pharmacists).

Aster's hospitals in India are located in Kochi, Kolhapur, Kozhikode, Kottakkal, Bengaluru, Vijayawada, Guntur, Wayanad and Hyderabad and are generally operated under the Aster, MIMS, Ramesh and Prime brands.

Company Promoters

1.       DR. AZAD MOOPEN

2.       UNION INVESTMENTS PRIVATE LIMITED

Company financial

(Rs in millions)

Registrar to the issue

1.      Link Intime India Private Limited

Lead Managers

1.       Kotak Mahindra Capital Company Limited

2.       Axis Capital Limited

3.       Goldman Sachs (India) Securities Private Limited

4.       ICICI Securities Limited

5.       JM Financial Institutional Securities Limited

6.       YES Securities (India) Limited

Objects of the Issue:

The Offer comprises the Fresh Issue and the Offer for Sale.

Company will not receive any proceeds from the Offer for Sale.

Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

1.       Repayment and/or pre-payment of debt.

2.       Purchase of medical equipment.

3.       General corporate purposes.

Risk factors

1.  This being the first public issue of our Company, there has been no formal market for the Equity Shares.

2.  Investments in equity and equity-related securities involve a degree of risk and investors should not invest any funds in the Offer unless they can afford to take the risk of losing their investment.